ACHE and Alzheimer disease: It should be noted that, in our cohort, patients were not treated with NMDA receptor antagonists (like memantine) (Robinson and Keating, 2006) or acetylcholinesterase inhibitors (like galantamine, rivastigmine, and donepezil) (Marucci et al., 2021), which are also known to act on AD pathophysiology.